Multi-Resistant Gram Negative Microorganisms St Elisabeth Hospital Curacao.

Slides:



Advertisements
Similar presentations
TREATMENT FOR SUPERIMPOSED PSEUDOMONAS AERUGINOSA INFECTION.
Advertisements

Microbiology Nuts & Bolts Session 2 Dr David Garner Consultant Microbiologist Frimley Park Hospital NHS Foundation Trust.
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
Antibiotic treatment choices for SBP Treviso 8 Giugno 2009 P. Angeli Dept. of Clinical and Experimental Medicine University of Padova.
Increasing transrectal ultrasound guided prostate biopsy associated infection; is a change in antimicrobial prophylaxis the solution? Authors: Ni Bhuachalla.
REALM project update MRSA and KPC January 26, 2011 Michael Lin, MD MPH on behalf of REALM co-investigators.
Enoch Omonge University of Nairobi
MANUAL on ALERT ORGANISM SURVEILLANCE
1 Emergence of Carbapenem-Resistant Klebsiella pneumoniae in an Acute Care Facility and the Potential Risk of Inter- Healthcare Facility Transmission Dawn.
Antimicrobial Resistant Enterobacteriaceae
Antimicrobial resistance surveillance in Ireland Results of invasive Pseudomonas aeruginosa infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.
Dr Katherine Watson ST1 Microbiology Antibiotic Management of Neutropenic Sepsis at The James Cook University Hospital.
Standard and Expanded Precautions
COL Helen Viscount, PhD, D(ABMM) LTC Steven Mahlen, PhD, D(ABMM)
Optimizing Antibiotics Dr Samir Sahu. Time to Antimicrobial Therapy KHL.
CHOICE OF ANTIBIOTICS IN THE VIEW OF DEVELOPING ANTIBIOTIC RESISTANCE Dr. Jolanta Miciulevičienė Vilnius City Clinical Hospital National Public Health.
MDR Organisms in Holy Family Hospital Rawalpindi
1 Extended spectrum B-lactamase producing E.coli in the community and in hospital Dr Graham Harvey Consultant Microbiologist Director of Infection Prevention.
Antimicrobial resistance surveillance in Ireland Results of invasive Escherichia coli infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.
Antimicrobial Stewardship St. Mary’s Hospital Infection Control Committee.
Do Physicians Find Our AST Reports As Confusing As We Do? Louis B. Rice, M.D. Louis Stokes Cleveland VA Medical Center and Case Western Reserve University.
Zunilda Djanun*, Rudyanto S**, Yulia Rosa***, *Dept. Clinical Pharmacology FMUI/CMH, **ICU CMH, *** Dept. Clinical Microbiology FMUI.
Controversies in managing neonatal infections David Isaacs Children’s Hospital at Westmead Sydney Australia.
RESULTS INTRODUCTION METHODS CONCLUSION  Extended spectrum beta-lactamases producing Enterobacteriacae (ESBLPE) have become a major cause of hospital-acquired.
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
김의종(집필대표), 강정옥, 김미나, 김민중, 김성일, 이경원, 이도현, 이장호, 이남용, 이창규, 신종희, 장철훈, 최혜심
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Antibiotics Affecting the Bacterial Cell Wall
EARS-Net data on Antimicrobial Resistance in Ireland, Q3 2015
INTRODUCTION TO INFECTION CONTROL ICNO Infection Control Unit, Teaching Hospital, Jaffna.
Antimicrobial resistance surveillance in Ireland Results of invasive Klebsiella pneumoniae infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Dr. Laila M. Matalqah Ph.D. Pharmacology
Le infezioni batteriche nel paziente oncoematologico Corrado Girmenia Ematologia, Azienda Policlinico Umberto I Sapienza University of Rome, Italy Ematologia.
An outbreak of ESBL-producing Klebsiella pneumoniae blood stream infection in a neonatal intensive care unit at University Hospital in Egypt F. Amer, E.
Using Nursing Home Antibiograms To Improve Antibiotic Prescribing and Delivery Training Slides for Nursing Home Nurses Comprehensive Antibiogram Toolkit.
How I deal with an outbreak? Prof Bertrand SOUWEINE Medical ICU Clermont-Ferrand France ISICEM March 2009.
Outcomes of Carbapenem-Resistant K. pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies Gopi Patel, MD; Shirish Huprikar, MD;
Tapasyapreeti Mukhopadhyay, Vrushali Patwardhan, Sarman Singh
Antimicrobial Stewardship/Statewide Antibiogram
N°XXXX Rapid detection of extended-spectrum BETA-lactamase producing Enterobacteriaceae from urine using the ESBL NDP test Patrice Nordmann, Laurent Poirel,
EARS-Net data on Antimicrobial Resistance in Ireland, Q
Number of Colonized / Infected Patients with MRSA in Ontario
The Role of the Microbiology Laboratory in AMS programs
Average susceptibility
Antimicrobial Spectrum of Activity Visual Learning Exercises (“Flower Diagrams”) This work is licensed under the Creative Commons Attribution-NonCommercial-
Reasons for non use of ACTs
Clinico-Pathological Conference (CPC) Meet
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
Antibiotics sensitivity of microorganism causing nosocomial infections
Septicemia And Septic Shock Overview Almataria Teaching Hospital, Nasser Institute Cairo, Egypt Dr. Mamdouh Sabry MD. Ain Shams, PhD. France Consultant.
Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type  A.K. Van der Bij, D. Van.
Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times  F.B. Spencker, L. Staber, T. Lietz,
CASE 4 Dr Sani Aliyu Consultant in Microbiology & Infectious Diseases Cambridge University Hospitals.
Carbapenemase-Producing Enterobacteriacea
Risk factors for carbapenem-resistant Enterobacteriaceae (CRE) carriage at the time of hospital admission Siddharth Mookerjee,1 Eleonora Dyakova,1 Frances.
Dr Lucinda Perkins Supervisor: Dr Jean Matthes 08/10/14
Changes to 10A NCAC 41A May 5, 2018.
Presenter: Julie Paronish Faculty Advisor: Nancy W. Glynn, PhD
The challenges of multi-drug-resistance in hepatology
EARS-Net data on Antimicrobial Resistance in Ireland, Q
Neonatal sepsis in Kilifi
BSAC Bacteraemia Resistance Surveillance Update 2013
Carbapenemase-Producing Enterobacteriacea
A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals  M. Nagao  Clinical Microbiology and.
The need for new antibiotics
Wastewater drainage system as an occult reservoir in a protracted clonal outbreak due to metallo-β-lactamase-producing Klebsiella oxytoca  S. Vergara-López,
Evolving problems with resistant pathogens
EARS-Net results 2011 Ole Heuer
EARS-Net data on Antimicrobial Resistance in Ireland, Q
Presentation transcript:

Multi-Resistant Gram Negative Microorganisms St Elisabeth Hospital Curacao

Marvis Djaoen, Dep. Infection Control SEHOS Marvis Djaoen, Dep. Infection Control SEHOS Liliana Daal, Dep. Infection Control SEHOS Liliana Daal, Dep. Infection Control SEHOS Dyanara Jean Pierre, Student Dyanara Jean Pierre, Student Eveline Roelofsen MD, Clinical Microbiologist Analytic Diagnostic Centre, Dep. Microbiology Eveline Roelofsen MD, Clinical Microbiologist Analytic Diagnostic Centre, Dep. Microbiology Willemien van Dijk MD PhD, Clinical Microbiologist, Dep. Infection Control SEHOS Willemien van Dijk MD PhD, Clinical Microbiologist, Dep. Infection Control SEHOS

Presentation Data St Elisabeth Hospital Curacao Data St Elisabeth Hospital Curacao 375 beds admissions year ICU (7 beds) and NICU (14 beds) Data on Multi Resistant Gram Neg Microorganisms in St Elisabeth Hospital over last years Data on Multi Resistant Gram Neg Microorganisms in St Elisabeth Hospital over last years Results of Prospective Pilot Study in 2007 Results of Prospective Pilot Study in 2007

Antimicrobial features of ESBL producing gram negative mo Most commonly the Enterobacteriaceae spp. Most commonly the Enterobacteriaceae spp. Usually confer resistance to: Usually confer resistance to: first-, second- and third-generation cephalosporin's monobactams carboxypenicillins carboxypenicillins Varied susceptibility to piperacillin/tazobactam Varied susceptibility to piperacillin/tazobactam Susceptible to carbapenems Susceptible to carbapenems

Multiresistant Gram negative mo Other than ESBL: criteria Resistant to at least two of the following antibiotics: Resistant to at least two of the following antibiotics: Aminoglycoside (gentamicin, tobramycin) Aminoglycoside (gentamicin, tobramycin) Quinolon (ciprofloxacin) Quinolon (ciprofloxacin) Third generation cephalosporin (ceftazidim) Third generation cephalosporin (ceftazidim) Piperacillin tazobactam Piperacillin tazobactamAND/OR Resistant to carbapenem (imipenem, meropenem) Resistant to carbapenem (imipenem, meropenem)

ESBL in Curacao 2001: Outbreak of ESBL producing Klebsiella pneumoniae in neonatal ward in St Elisabeth Hospital 2001: Outbreak of ESBL producing Klebsiella pneumoniae in neonatal ward in St Elisabeth Hospital 26 Neonates affected 26 Neonates affected

ESBL in St Elisabeth Hospital

Multiresistant Gram negative MO other than ESBL in St. Elisabeth Hospital

Yearly increase Resistant Gram neg MO in St Elisabeth Hospital

Trend Yearly new Patients with resistant Gram- neg MO

ESBL microorganisms St Elisabeth Hospital

Resistant Gram Neg mo (ESBL and MRGNMO)

Duration of hospitalization and 1 st isolaton of MR Gram Neg MO (2007)

Cases of MR Gram-Neg MO Hospitalization as risk factor Never in hospital 23 % 23 % (15 % neonates) 20 % (8%neonates) 19 % In hospital last year 47 % 49 %

2007 Pilot study Patients colonized at admission ? Patients colonized at admission ? Patients colonized during hospital stay ? Patients colonized during hospital stay ? How soon after admission are patients colonized ? How soon after admission are patients colonized ? Is previous hospitalization a risk factor ? Is previous hospitalization a risk factor ? Prospective study Prospective study 2 month’s period 2 month’s period

2007 Pilot study 3 nursery wards: 3 nursery wards: Surgical Man (41 Beds), Surgical Man (41 Beds), Internal Man ( 32 Beds), Internal Man ( 32 Beds), General Woman (18 Beds) General Woman (18 Beds) All Patients included at admission All Patients included at admission

2007 Pilot study Rectal swab taken: Rectal swab taken: Admission Admission Weekly Weekly Departure Departure Selective media : BHI wit Vancomycin and Cefazolin Selective media : BHI wit Vancomycin and Cefazolin Identification and resistance : Vitek ® automated system Identification and resistance : Vitek ® automated system ESBL confirmation with disc method ESBL confirmation with disc method

Patients colonized at admission and during hospitalization Number patients admission during hospital stay Surgical Man (10.1 %) 29 (14.6 %) Internal Man (2.6 %) 14 (11.9 %) General Woman 60 1 (1.7 %) 8 (13.3%) Total (6.4 %) 51 (13.6 %)

Multi Resistant Gram Neg MO isolated at admission E.Coli13 ESBL 8 Klebsiella7 ESBL 7 Pseud1 Other3 Total24 ESBL 15 (63%)

Multi Resistant Gram Neg MO isolated during stay in hospital E.Coli48 ESBL 27 Klebsiella21 ESBL 20 Pseud6 Other4 ESBL 2 Total66 ESBL 49 (74 %)

Hospitalization as risk factor Colonized at admission Colonized in hospital Not hospitalized last year 221 (59 %) 10 (4.5 %) 32 (14.5 %) hospitalized year before admission 154 (41 %) 14 (9.1 %) 19 (12.3 %)

Duration of hospitalization and 1 st isolaton of MR Gram Neg MO

Summarized Pilot Study 375 patients 375 patients 6 % colonized at admission 6 % colonized at admission 14 % colonized during hospital stay 14 % colonized during hospital stay 20 % colonized leaving the hospital 20 % colonized leaving the hospital 53 % Multi resistant E. coli 53 % Multi resistant E. coli 31 % Multi resistant Klebsiella 31 % Multi resistant Klebsiella 69 % ESBL 69 % ESBL Patients are colonized early during hospital stay Patients are colonized early during hospital stay Previous hospitalization probably risk factor, but needs further analysis Previous hospitalization probably risk factor, but needs further analysis

Summary Resistant Gram negative Microorganisms are emerging in the hospital over the last years Resistant Gram negative Microorganisms are emerging in the hospital over the last years Many resistant microorganisms are ESBL positive Many resistant microorganisms are ESBL positive At admission < 5 % of patients, not recently hospitalized, colonized with MRGNMO At admission < 5 % of patients, not recently hospitalized, colonized with MRGNMO At discharge from hospital probably 20 % is colonized with MRGNMO At discharge from hospital probably 20 % is colonized with MRGNMO

Surveillance of antibiotic resistance is important and should be improved Surveillance of antibiotic resistance is important and should be improved Spread of multiresistant microorganisms in the hospital must be prevented with all possible methods. Spread of multiresistant microorganisms in the hospital must be prevented with all possible methods.

Materials MR Gram Neg isolated 2007 Clinical specimens 62 % blood 7.4 % urine 23.8 % wound 18.2 % Respiratory tract 10.3 % Non Clinical ( rectal, throat) 38 %

Resistant Gram Neg MO isolated E.Coli48 ESBL 33 Klebsiella28 ESBL 27 Pseudomonas7 Other7 ESBL 2 Total90 ESBL 62 (69 %)

Hospitalization as risk factor Colonized at admission Colonized at discharge Not hospitalized last year 221 (59 %) 10 (4.5 %) 42 (19 %) hospitalized year before admission 154 (41 %) 14 (9.1 %) 33 (21 %) total (6.4 %) 75 (20 %)